Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 42.43 | -17.78 |
PEG Ratio (TTM) | 0.42 | -5.55 |
P/S Ratio (TTM) | N/A | 39.43 |
P/B Ratio (TTM) | 1.61 | 5.80 |
P/FCF Ratio (TTM) | -146.27 | -146.47 |
Price to 5YR AVG Earnings Ratio | N/A | -34.01 |
Price to 5YR AVG FCF Ratio | N/A | -1.00 |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | 3.64% | 288.99% |
ROE (TTM) | 3.86% | -4,244.29% |
Net Profit Margin (TTM) | N/A | -1,050.76% |
ROIC 5YR AVG | N/A | -15.85% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 191.56% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -0.71% | N/A | N/A |
Cash Flow | -67.63% | N/A | N/A |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.81 | 4.94 |
Quick Ratio (TTM) | 0.81 | 4.92 |
D/E Ratio (TTM) | N/A | 1.30 |
Interest Coverage (TTM) | 0.09 | -11.46 |
Piotroski F-Score | 2 | 3 |
Altman Z-Score | 4.46 | 21.03 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 892.04% |